Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death

Geoffrey G. Hicks, Nagendra Singh, Abudi Nashabi, Sabine Mai, Gracjan Bozek, Ludger Klewes, Djula Arapovic, Erica K. White, Mark J. Koury, Eugene M. Oltz, Luc Van Kaer, H. Earl Ruley

Research output: Contribution to journalArticlepeer-review

241 Scopus citations

Abstract

The gene FUS (also known as TLS (for translocated in liposarcoma) and hnRNP P2) is translocated with the gene encoding the transcription factor ERG-1 in human myeloid leukaemias. Although the functions of wild-type FUS are unknown, the protein contains an RNA-recognition motif and is a component of nuclear riboprotein complexes. FUS resembles a transcription factor in that it binds DNA, contributes a transcriptional activation domain to the FUS-ERG oncoprotein and interacts with several transcription factors in vitro. To better understand FUS function in vivo, we examined the consequences of disrupting Fus in mice. Our results indicate that Fus is essential for viability of neonatal animals, influences lymphocyte development in a non-cell-intrinsic manner, has an intrinsic role in the proliferative responses of B cells to specific mitogenic stimuli and is required for the maintenance of genomic stability. The involvement of a nuclear riboprotein in these processes in vivo indicates that Fus is important in genome maintenance.

Original languageEnglish (US)
Pages (from-to)175-179
Number of pages5
JournalNature Genetics
Volume24
Issue number2
DOIs
StatePublished - Feb 2000
Externally publishedYes

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death'. Together they form a unique fingerprint.

Cite this